LENZ Therapeutics Inc.

AI Score

0

Unlock

21.53
-0.01 (-0.05%)
At close: Mar 04, 2025, 1:12 PM

LENZ Therapeutics Ratios Statement

Year FY23 FY22 FY21 FY20 FY19
PE Ratio -0.81 -1.22 -6.89 -10.63 -6.67K
PEG Ratio -0.04 -0.02 -1.9 -0.00 n/a
PS Ratio n/a 8.21 n/a n/a n/a
PB Ratio 0.55 0.42 1.25 -74.13 -327.54
P/FCF Ratio -1 -1.3 -8.32 -70.77 -38.24K
P/OCF Ratio -1.12 -1.4 -9.22 -83.3 -38.24K
OCF/S Ratio n/a -5.87 n/a n/a n/a
Debt / Equity Ratio 0.00 0.02 n/a n/a -0.99
Quick Ratio 39.20 21.11 31.44 0.66 0.00
Current Ratio 39.20 21.11 31.44 0.66 0.00
Asset Turnover n/a 0.05 n/a n/a n/a
Interest Coverage n/a n/a n/a -337.5 -0.36
Return on Equity (ROE) -0.68 -0.34 -0.18 6.98 0.05
Return on Assets (ROA) -0.66 -0.31 -0.18 -3.03 -18.17
Return on Capital (ROIC) -0.4 -0.34 -0.16 1.42 0.01
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a 44.36% n/a n/a n/a
Net Profit Margin n/a -673.68% n/a n/a n/a
Pretax Profit Margin n/a -673.68% n/a n/a n/a
Operating Profit Margin n/a -704.26% n/a n/a n/a
FCF Margin n/a -630.49% n/a n/a n/a
EBITDA Margin n/a -648.62% n/a n/a n/a